USANA Health Sciences Future Growth
Future criteria checks 0/6
USANA Health Sciences's earnings are forecast to decline at 2.2% per annum while its annual revenue is expected to grow at 0.5% per year. EPS is expected to decline by 2.2% per annum.
Key information
-2.2%
Earnings growth rate
-2.2%
EPS growth rate
Personal Products earnings growth | 23.2% |
Revenue growth rate | 0.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 14 Oct 2024 |
Recent future growth updates
USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Recent updates
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Sep 26Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?
Sep 08USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding
Jul 17USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively
May 29USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?
May 31Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 878 | 52 | 64 | 80 | 2 |
12/31/2024 | 862 | 48 | 53 | 71 | 2 |
6/29/2024 | 875 | 55 | 59 | 74 | N/A |
3/30/2024 | 900 | 62 | 60 | 75 | N/A |
12/30/2023 | 921 | 64 | 56 | 71 | N/A |
9/30/2023 | 928 | 60 | 75 | 85 | N/A |
7/1/2023 | 948 | 63 | 79 | 92 | N/A |
4/1/2023 | 974 | 65 | 86 | 97 | N/A |
12/31/2022 | 999 | 69 | 94 | 104 | N/A |
10/1/2022 | 1,038 | 77 | 78 | 88 | N/A |
7/2/2022 | 1,079 | 89 | 84 | 97 | N/A |
4/2/2022 | 1,151 | 108 | 108 | 121 | N/A |
1/1/2022 | 1,186 | 117 | 108 | 121 | N/A |
10/2/2021 | 1,230 | 136 | 133 | 144 | N/A |
7/3/2021 | 1,254 | 139 | 148 | 156 | N/A |
4/3/2021 | 1,176 | 129 | 140 | 149 | N/A |
1/2/2021 | 1,135 | 125 | 145 | 160 | N/A |
9/26/2020 | 1,095 | 116 | 149 | 168 | N/A |
6/27/2020 | 1,058 | 110 | 149 | 169 | N/A |
3/28/2020 | 1,055 | 103 | 131 | 152 | N/A |
12/28/2019 | 1,061 | 101 | 110 | 127 | N/A |
9/28/2019 | 1,089 | 102 | 97 | 111 | N/A |
6/29/2019 | 1,125 | 109 | 104 | 116 | N/A |
3/30/2019 | 1,170 | 121 | 127 | 138 | N/A |
12/29/2018 | 1,189 | 126 | 141 | 152 | N/A |
9/29/2018 | 1,163 | 88 | 154 | 167 | N/A |
6/30/2018 | 1,128 | 81 | 112 | 125 | N/A |
3/31/2018 | 1,084 | 70 | N/A | 141 | N/A |
12/30/2017 | 1,047 | 63 | N/A | 124 | N/A |
9/30/2017 | 1,027 | 90 | N/A | 124 | N/A |
7/1/2017 | 1,020 | 97 | N/A | 145 | N/A |
4/1/2017 | 1,021 | 99 | N/A | 125 | N/A |
12/31/2016 | 1,006 | 100 | N/A | 137 | N/A |
10/1/2016 | 986 | 102 | N/A | 119 | N/A |
7/2/2016 | 965 | 98 | N/A | 113 | N/A |
4/2/2016 | 940 | 97 | N/A | 101 | N/A |
1/2/2016 | 918 | 95 | N/A | 111 | N/A |
10/3/2015 | 914 | 92 | N/A | 112 | N/A |
7/4/2015 | 872 | 86 | N/A | 120 | N/A |
4/4/2015 | 827 | 80 | N/A | 126 | N/A |
1/3/2015 | 790 | 77 | N/A | 105 | N/A |
9/27/2014 | 749 | 76 | N/A | 102 | N/A |
6/28/2014 | 731 | 73 | N/A | 83 | N/A |
3/29/2014 | 731 | 78 | N/A | 81 | N/A |
12/28/2013 | 718 | 79 | N/A | 99 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: USNA's earnings are forecast to decline over the next 3 years (-2.2% per year).
Earnings vs Market: USNA's earnings are forecast to decline over the next 3 years (-2.2% per year).
High Growth Earnings: USNA's earnings are forecast to decline over the next 3 years.
Revenue vs Market: USNA's revenue (0.5% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: USNA's revenue (0.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if USNA's Return on Equity is forecast to be high in 3 years time